Skip to main
GMED

Globus Medical (GMED) Stock Forecast & Price Target

Globus Medical (GMED) Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 36%
Buy 45%
Hold 18%
Sell 0%
Strong Sell 0%

Bulls say

Globus Medical is well-positioned for growth with its focus on the high-growth medical device market, strong financial position, and successful track record in the spinal robotics industry. Its expanding international presence and emphasis on recurring revenue sources bode well for long-term stability and profitability. With a CEO who has a 96% approval rating and a company culture that values innovation, Globus Medical maintains a competitive edge in the industry and has a positive outlook for future performance.

Bears say

Globus Medical is currently facing a challenging environment, with intense competition in its core musculoskeletal solutions business and pressure on its enabling technologies segment. Additionally, the company's aggressive acquisition strategy may lead to potential integration challenges and financial strain. These factors, along with the lack of a dedicated sustainability strategy, contribute to the analyst's negative outlook on the stock.

Globus Medical (GMED) has been analyzed by 11 analysts, with a consensus rating of Buy. 36% of analysts recommend a Strong Buy, 45% recommend Buy, 18% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Globus Medical and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Globus Medical (GMED) Forecast

Analysts have given Globus Medical (GMED) a Buy based on their latest research and market trends.

According to 11 analysts, Globus Medical (GMED) has a Buy consensus rating as of Jun 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $103.36, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $103.36, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Globus Medical (GMED)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.